Palvella Therapeutics, Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2020-11-04: Form 10-Q; Exhibit 10.1; Description Clinical Trial Collaboration and Supply Agreement, dated August 10, 2020, by and between Pieris Pharmaceuticals, Inc. and Eli Lilly and Company..
- 2020-08-10: Form 10-Q; Exhibit 10.3; Description Amendment No. 1 to the February 8, 2018 Platform Agreement by and among Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH and Seattle Genetics, Inc..
- 2020-08-10: Form 10-Q; Exhibit 10.2; Description Amendment No. 1 to the February 8, 2018 License and Collaboration Agreement by and among Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH and Seattle Genetics, Inc..
- 2020-06-29: Form 8-K; Exhibit 10.1; Description Pieris Pharmaceuticals, Inc. 2020 Employee, Director and Consultant Equity Incentive Plan..
| Filed | Form | Exhibit | Description |
|---|
| 2020-11-04 | 10-Q | 10.1 | Clinical Trial Collaboration and Supply Agreement, dated August 10, 2020, by and between Pieris Pharmaceuticals, Inc. and Eli Lilly and Company. |
|---|
| 2020-08-10 | 10-Q | 10.3 | Amendment No. 1 to the February 8, 2018 Platform Agreement by and among Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH and Seattle Genetics, Inc. |
|---|
| 2020-08-10 | 10-Q | 10.2 | Amendment No. 1 to the February 8, 2018 License and Collaboration Agreement by and among Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH and Seattle Genetics, Inc. |
|---|
| 2020-06-29 | 8-K | 10.1 | Pieris Pharmaceuticals, Inc. 2020 Employee, Director and Consultant Equity Incentive Plan. |
|---|
| 2020-04-06 | 8-K | 10.1 | Exchange Agreement by and among Pieris Pharmaceuticals, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., and Biotechnology Value Trading Fund OS, L.P., dated as of March 31, 2020. |
|---|
| 2020-03-13 | 10-K | 10.32 | Amendment No. 2 to Lease Agreement by and between Pieris GmbH and Hallbergmoos Grundvermögen GmbH, dated February 13, 2020 (English translation) |
|---|
| 2020-03-13 | 10-K | 10.31 | Amendment No. 1 to Lease Agreement by and between Pieris GmbH and Hallbergmoos Grundvermögen GmbH, dated May 21, 2019 (English translation) |
|---|
| 2020-03-13 | 10-K | 10.26 | Non-Employee Director Compensation Policy, as amended |
|---|
| 2020-03-13 | 10-K | 10.25 | Letter Agreement by and between the Registrant and Louis A. Matis, M.D., dated as of January 8, 2020 |
|---|
| 2020-03-13 | 10-K | 10.16 | Letter Amendment to the License and Collaboration Agreement by and between Les Laboratoires Servier, Institut de Recherches Internationales Servier, Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH, effective as of January 3, 2020 |
|---|